Preoperative pain control using intraarticular multimodal drugs injection in femoral neck fracture

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230918005

Enrollment

Registered

2023-09-18

Start date

2023-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preoperative femoral neck fracture pain control preoperative femoral neck fracture intraarticular injection

Interventions

study efficacy of IA MDI using Levobupivacaine 25 mg Ketorolac 30 mg Morphine 10 mg Cefuroxime 750 mg Adrenaline 300 mcg in preoperative femoral neck fracture patient (before definite surgery

Experimental Procedure/Surgery

IA MDI (Levobupivacaine, Ketorolac, Morphine, Adrenaline, Cefuroxime) preoperative femoral neck fracture vs standard IV morphine injection

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.equal or more than 60 years old patient 2.Low energy closed Femoral neck fracture (subcapital and transcervical type) 3.Willing to participate in the study

Exclusion criteria

Exclusion criteria: Pathological fracture other than osteoporosis Previous ipsilateral OA hip Multiple trauma or fractures Acute fracture(<72hours) Had previous ipsilateral hip fracture or surgery Allergy to the medications and contrast used in protocol GFR < 60ml/min/1.73m2 DM poor controlled (HbA1C > 8%) Current systemic steroid use Local infection at injection site Severe cognitive impairment that affects data collection

Design outcomes

Primary

Measure	Time frame
pain score 20 minutes, 4,8,16,20,24,28,32,36 hours after trauma ( before definite surgery) pain score	—

Secondary

Measure	Time frame
complications (Delirium, CAD, GI bleeding) before definite surgery rates of event	—

Countries

Thailand

Contacts

Public ContactKonlawat Sabsuantang

Faculty of medicine Ramathibodi hospital, Mahidol university

konlawat_s@hotmail.com028396151

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026